SPRO
#3879
Spero Therapeutics, Inc. - Common Stock
2.1 8 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.81%
Monthly Change
-25.60%
6 month change
-12.80%
Year Change
-16.48%
Previous Close
2.1 0
Open
2.1 8
Low
2.1 8
High
2.1 8
Volume
17
Financials
- Market Capitalization 126.23 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.53
Price to sales ratio
2.06
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3866 |  GNLX Genelux Corporation - Common Stock | 2.96 USD | -2.31% | -1.66% | -1.66% | -12.17% | 132.73 M USD | ||
| 3871 |  AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 USD | -21.58% | +1.36% | +52.82% | -52.74% | 130.03 M USD | ||
| 3884 |  CUE Cue Biopharma, Inc. - Common Stock | 30.92 USD | -15.93% | -5.93% | +26.05% | +3968.42% | 125.09 M USD | ||
| 3885 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.86 USD | -2.11% | -2.62% | +6.29% | -77.86% | 124.60 M USD |
Frequently asked questions about Spero Therapeutics, Inc. - Common Stock
What is the Spero Therapeutics, Inc. - Common Stock stock price today?
The current price of Spero Therapeutics, Inc. - Common Stock (SPRO) is 2.18. Over the past 24 hours, the stock has changed by +3.81%. Follow the SPRO chart for real-time price dynamics.
What is the stock ticker of Spero Therapeutics, Inc. - Common Stock?
Spero Therapeutics, Inc. - Common Stock trades under the ticker SPRO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spero Therapeutics, Inc. - Common Stock stock going up?
SPRO has changed by +0.93% over the last week, -25.60% over the last month, and -16.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Spero Therapeutics, Inc. - Common Stock net income for the last quarter?
Spero Therapeutics, Inc. - Common Stock reported net income of -7.2 M for the last quarter. The previous quarter showed 31.52 M, which means net income changed by -122.85%.
How many employees does Spero Therapeutics, Inc. - Common Stock have?
As of the latest available data, Spero Therapeutics, Inc. - Common Stock has 25 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Spero Therapeutics, Inc. - Common Stock stock?
You can buy Spero Therapeutics, Inc. - Common Stock (SPRO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spero Therapeutics, Inc. - Common Stock stock?
Investing in Spero Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SPRO chart and related analysis on metatrader.com as part of your research.